EVOKE PHARMA INC's ticker is EVOK and the CUSIP is 30049G104. A total of 20 filers reported holding EVOKE PHARMA INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $0 | -100.0% | 1,000 | 0.0% | 0.00% | – |
Q4 2021 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q3 2021 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q2 2021 | $1,000 | -50.0% | 1,000 | 0.0% | 0.00% | – |
Q1 2021 | $2,000 | -33.3% | 1,000 | 0.0% | 0.00% | -100.0% |
Q4 2020 | $3,000 | -40.0% | 1,000 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $5,000 | +25.0% | 1,000 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $4,000 | +300.0% | 1,000 | 0.0% | 0.00% | – |
Q1 2020 | $1,000 | -50.0% | 1,000 | 0.0% | 0.00% | -100.0% |
Q4 2019 | $2,000 | +100.0% | 1,000 | 0.0% | 0.00% | – |
Q3 2019 | $1,000 | – | 1,000 | 0.0% | 0.00% | – |
Q2 2019 | $0 | -100.0% | 1,000 | 0.0% | 0.00% | – |
Q1 2019 | $1,000 | -50.0% | 1,000 | 0.0% | 0.00% | -100.0% |
Q4 2018 | $2,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 259,100 | $1,355,000 | 0.54% |
Knoll Capital Management, LLC | 55,660 | $291,000 | 0.09% |
Financial Architects, Inc | 2,150 | $11,000 | 0.00% |
Tower Research Capital LLC (TRC) | 1,396 | $7,000 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 15,864 | $82,000 | 0.00% |
BlackRock Investment Management, LLC | 489 | $3,000 | 0.00% |
DEUTSCHE BANK AG\ | 1,062 | $5,000 | 0.00% |
MORGAN STANLEY | 1,661 | $9,000 | 0.00% |
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 36,700 | $192,000 | 0.00% |
Renaissance Technologies | 13,024 | $68,000 | 0.00% |